PLCL1 rs7595412 variation is not associated with hip bone size variation in postmenopausal Danish women
- PMID: 20030815
- PMCID: PMC2803169
- DOI: 10.1186/1471-2350-10-145
PLCL1 rs7595412 variation is not associated with hip bone size variation in postmenopausal Danish women
Abstract
Background: Bone size (BS) variation is under strong genetic control and plays an important role in determining bone strength and fracture risk. Recently, a genome-wide association study identified polymorphisms associated with hip BS variation in the PLCL1 (phospholipase c-like 1) locus. Carriers of the major A allele of the most significant polymorphism, rs7595412, have around 17% larger hip BS than non-carriers. We therefore hypothesized that this polymorphism may also influence postmenopausal complications.
Methods: The effects of rs7595412 on hip BS, bone mineral density (BMD), vertebral fractures, serum Crosslaps and osteocalcin levels were analyzed in 1,191 postmenopausal Danish women.
Results: This polymorphism had no influence on hip and spine BS as well as on femur and spine BMD. Women carrying at least one copy of the A allele had lower levels of serum osteocalcin as compared with those homozygous for the G allele (p = 0.03) whereas no effect on serum Crosslaps was detected. Furthermore, women homozygous for the A allele were more affected by vertebral fractures than those carrying at least one copy of the G allele (p = 0.04).
Conclusions: In postmenopausal women, our results suggest that the PLCL1 rs7595412 polymorphism has no obvious effect on hip BS or BMD but may be nominally associated with increased proportion of vertebral fracture and increased levels of osteocalcin.
Similar articles
-
Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk.Osteoporos Int. 2011 Apr;22(4):1145-56. doi: 10.1007/s00198-010-1292-4. Epub 2010 Jun 23. Osteoporos Int. 2011. PMID: 20571774 Clinical Trial.
-
Identification of PLCL1 gene for hip bone size variation in females in a genome-wide association study.PLoS One. 2008 Sep 8;3(9):e3160. doi: 10.1371/journal.pone.0003160. PLoS One. 2008. PMID: 18776929 Free PMC article.
-
Evaluation of ERα and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women.Mol Biol Rep. 2012 Jun;39(6):6723-30. doi: 10.1007/s11033-012-1496-0. Epub 2012 Feb 7. Mol Biol Rep. 2012. PMID: 22311020
-
Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women.Osteoporos Int. 2011 Apr;22(4):1219-25. doi: 10.1007/s00198-010-1312-4. Epub 2010 Jun 8. Osteoporos Int. 2011. PMID: 20532479
-
Polymorphisms in the Runx2 and osteocalcin genes affect BMD in postmenopausal women: a systematic review and meta-analysis.Endocrine. 2024 Apr;84(1):63-75. doi: 10.1007/s12020-023-03621-2. Epub 2023 Dec 6. Endocrine. 2024. PMID: 38055125
References
-
- Yang TL, Chen XD, Guo Y, Lei SF, Wang JT, Zhou Q, Pan F, Chen Y, Zhang ZX, Dong SS, Xu XH, Yan H, Liu X, Qiu C, Zhu XZ, Chen T, Li M, Zhang H, Zhang L, Drees BM, Hamilton JJ, Papasian CJ, Recker RR, Song XP, Cheng J, Deng HW. Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet. 2008;83(6):663–674. doi: 10.1016/j.ajhg.2008.10.006. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical